Who Are We?

The U.S. Food and Drug Administration (FDA) awarded a prestigious P50 grant to the SouthWest national Pediatric Device innovation Consortium (SWPDC), that began on Sept. 1, 2018 and will last for five years. The consortium, based at Texas Children’s Hospital and Baylor College of Medicine and led by Chester Koh, MD, is one of five recipients across the country; other PDCs are located in Philadelphia, Washington D.C., San Francisco, and Los Angeles. Altogether, the five PDC will receive up to $6 million per year over the next five years.

SWPDC supports pediatric device innovators with product and technology acceleration services and business acceleration services both regionally and nationally, with the goal of commercialization and clinical use of novel pediatric medical devices.

The consortium includes clinical, scientific, business, financial, regulatory, reimbursement, engineering, ISO13485 compliant product design & manufacturing, intellectual property, and academic partners in the Houston / Southwest U.S. region, including Texas A&M University, Rice University, University of Houston, Fannin Innovation Studio, local device development firms, and other children’s hospitals in the Southwest U.S. region (including Children's Hospital of San Antonio, Children's Health in Dallas, and Phoenix Children's).

The consortium recognizes that pediatric device projects may need an extended life cycle in the children’s hospital / academic setting before exposure to the external market. To this end, it has partnered with faculty, students, and resources of major children's hospitals and established engineering design teams at major research universities to identify unmet pediatric device needs, and then design and test new pediatric device prototypes that can be developed into viable pediatric medical devices.